Cosentyx goes head to head against Humira in psoriatic arthritis…it’s mostly a draw

…study designed and funded by Novartis, the company behind Cosentyx. The study pitted Cosentyx against Humira for 52 weeks in adults with active psoriatic arthritis who were new to biologic…

Psoriasis & Psoriatic Arthritis Treatment Options

Cosentyx patients were still 90% improved. Safety was comparable between Cosentyx and Stelara. In addition, after 12 weeks, about one quarter of Cosentyx patients were 100% improved: their skin was…

Treatments for Inverse, Guttate, Pustular, & Erythrodermic Psoriasis

…can be treated with fast-acting medications like cyclosporine or Remicade. Other treatment options include Soriatane, methotrexate, or biologics such as Enbrel, Stelara, Cosentyx, or Taltz. There are indications that another…

The Latest Psoriasis News

Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and the new biologic Skyrizi (risankizumab-rzaa), has asked the U.S. Food and Drug Administration (FDA) and its European counterpart to approve its rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for psoriatic arthritis. Rinvoq is a JAK inhibitor administered as Continue Reading…

Our new “Psoriasis Journey” campaign is rolling out

Our new Psoriasis Journey campaign is rolling out now to prep for for an official June 8, 2020 launch. On that date, our volunteer patient with severe psoriasis is going to begin one of the cutting-edge psoriasis treatments we’ve been hearing so much about. You can follow along with his Continue Reading…

Want to try an experimental psoriasis treatment for your skin or scalp?

Before a doctor can prescribe a treatment, it goes through years of research and testing, including multiple rounds of clinical trials, using volunteer patients to test a potential treatment’s safety and effectiveness. The clinical trials are developed in consultation with government regulators (here, the US Food and Drug Administration, or Continue Reading…